The AlphaLISA® immunoassay kit for human Kidney Injury Molecule 1 (KIM-1) enables the quantitative determination of human KIM-1 in buffered solution, urine, cell culture media, and cell lysates using a homogeneous AlphaLISA assay (no wash steps).
Item(s) added to cart.
For research use only. Not for use in diagnostic procedures.
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
AlphaLISA technology allows the detection of molecules of interest in buffer, cell culture media, serum and plasma in a highly sensitive, quantitative, reproducible and user-friendly mode. In an AlphaLISA assay, a Biotinylated Anti-Analyte Antibody binds to the Streptavidin-coated Alpha Donor beads, while another Anti-Analyte Antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
Kidney Injury Molecule 1 (KIM-1), also known as Hepatitis A virus cellular receptor1 (HAVcr-1) and T-cell immunoglobulin and mucin domain 1 (TIM-1), is a type 1 transmembrane protein containing mucin and immunoglobulin domains. KIM-1 is widely expressed with the highest levels in kidney and testis. KIM-1 serves as a biomarker of renal damage, specifically proximal tubular injury. Patients with renal carcinoma or acute tubular necrosis, for example, experience a drastic increase of KIM-1 in their serum or urine. This detection kit is designed to quantify KIM-1 in urine, serum and cell culture media.
|Assay Target Class||Protein|
|Product Brand Name||AlphaLISA|
|Shipping Condition||Blue Ice|
|Unit Size||500 Assay Points|